INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts.

Abstract:

BACKGROUND:Regulatory T cells (Tregs), particularly the CD4(+)CD25(+)Foxp3(+) Tregs, down regulate immunity and promote tumor cell growth by directly suppressing CD8(+) and CD4(+) T cells. Alternatively they can promote tumor growth by generating interleukin-10 (IL-10) and transforming growth factor β (TGFβ) in situ, which help tumor cells to evade the immune system. METHODS:In vivo tumor models were prepared via subcutaneous injection with a suspension of B16 melanoma cells into the left upper flank of C57BL/6 J mice. The mice were randomized into five groups: radiotherapy (RT), chemotherapy (CT), radiochemotherapy (RCT), Inteferon α (INFα) groups, and a control group. Flow cytometry was used to determine the Tregs levels in the spleen and peripheral blood, and immunohistochemistry was performed to determine the expression levels of TGFβ and IL-10 in the tumor microenvironment. RESULTS:Tumor weight was significantly reduced in the CT or RCT groups (40.91 % and 41.83 %, respectively), while the reduction in tumor weight was relatively lower for the RT and IFNα groups (15.10 % and 13.15 %, respectively). The flow cytometry results showed that the ratios of CD4(+)CD25(+)Foxp3(+) Tregs to lymphocytes and CD4(+) cells in the spleen and in peripheral blood were significantly decreased after treatment with IFNα (P < 0.05). Expression of TGFβ and IL-10 in the tumor microenvironment in the CT and RT groups was higher compared with the control group (P < 0.01), while the expression of TGFβ and IL-10 in the INFα group was not significantly different (P > 0.05). CONCLUSIONS:The results show that INFα-2b inhibits cancer cell immune evasion by decreasing the levels of CD4(+)CD25(+)Foxp3(+) Tregs and suppressing the expression of TGFβ and IL-10 in the tumor microenvironment.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Yu Y,Huang R,Zong X,He X,Mo W

doi

10.1186/s12885-016-2473-0

subject

Has Abstract

pub_date

2016-07-07 00:00:00

pages

397

issn

1471-2407

pii

10.1186/s12885-016-2473-0

journal_volume

16

pub_type

杂志文章
  • Mindfulness-based interventions and cognitive function among breast cancer survivors: a systematic review.

    abstract:BACKGROUND:Breast cancer survivors have an elevated risk of cognitive impairment compared to age-matched women without cancer. Causes of this impairment are complex, including both treatment and psychological factors. Mindfulness-based interventions, which have been shown to improve cognitive function in the general po...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-5065-3

    authors: Cifu G,Power MC,Shomstein S,Arem H

    更新日期:2018-11-26 00:00:00

  • Lung cancer symptoms and pulse oximetry in the prognostic assessment of patients with lung cancer.

    abstract:BACKGROUND:Medical oncologists continue to use performance status as a proxy for quality of life (QOL) measures, as completion of QOL instruments is perceived as time consuming, may measure aspects of QOL not affected by cancer therapy, and interpretation may be unclear. The pulse oximeter is widely used in clinical pr...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-5-72

    authors: Martins SJ,Ho N,Cavamura SO,Harada CM,Yamamoto CA,Takagaki TY

    更新日期:2005-07-06 00:00:00

  • The effect of neoadjuvant chemotherapy and chemoradiotherapy on exercise capacity and outcome following upper gastrointestinal cancer surgery: an observational cohort study.

    abstract:BACKGROUND:In 2014 approximately 21,200 patients were diagnosed with oesophageal and gastric cancer in England and Wales, of whom 37 % underwent planned curative treatments. Potentially curative surgical resection is associated with significant morbidity and mortality. For operable locally advanced disease, neoadjuvant...

    journal_title:BMC cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1186/s12885-016-2682-6

    authors: West MA,Loughney L,Ambler G,Dimitrov BD,Kelly JJ,Mythen MG,Sturgess R,Calverley PM,Kendrick A,Grocott MP,Jack S

    更新日期:2016-09-02 00:00:00

  • Effects of leucine supplemented diet on intestinal absorption in tumor bearing pregnant rats.

    abstract:BACKGROUND:It is known that amino acid oxidation is increased in tumor-bearing rat muscles and that leucine is an important ketogenic amino acid that provides energy to the skeletal muscle. METHODS:To evaluate the effects of a leucine supplemented diet on the intestinal absorption alterations produced by Walker 256, g...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-2-7

    authors: Ventrucci G,de Mello MA,Gomes-Marcondes MC

    更新日期:2002-04-15 00:00:00

  • Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens.

    abstract:BACKGROUND:Compared with World Health Organization-defined acute myeloid leukaemia (AML) not otherwise specified, patients with AML with myelodysplasia-related changes (AML-MRC) are generally older and more likely to have poor-risk cytogenetics, leading to poor response and prognosis. More than one-half of all older (≥...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/s12885-017-3803-6

    authors: Seymour JF,Döhner H,Butrym A,Wierzbowska A,Selleslag D,Jang JH,Kumar R,Cavenagh J,Schuh AC,Candoni A,Récher C,Sandhu I,Del Castillo TB,Al-Ali HK,Falantes J,Stone RM,Minden MD,Weaver J,Songer S,Beach CL,Dombret H

    更新日期:2017-12-14 00:00:00

  • Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3.

    abstract:BACKGROUND:Extravasation of circulating cancer cells is a key event of metastatic dissemination that is initiated by the adhesion of cancer cells to endothelial cells. It requires interactions between adhesion receptors on endothelial cells and their counter-receptors on cancer cells. Notably, E-selectin, a major endot...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-11-285

    authors: Porquet N,Poirier A,Houle F,Pin AL,Gout S,Tremblay PL,Paquet ER,Klinck R,Auger FA,Huot J

    更新日期:2011-07-01 00:00:00

  • Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma.

    abstract:BACKGROUND:New biomarkers are needed for the prognosis of advanced colorectal cancer, which remains incurable by conventional treatments. O6-methylguanine DNA methyltransferase (MGMT) methylation and protein expression have been related to colorectal cancer treatment failure and tumor progression. Moreover, the presenc...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-511

    authors: Oliver JA,Ortiz R,Melguizo C,Alvarez PJ,Gómez-Millán J,Prados J

    更新日期:2014-07-11 00:00:00

  • Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy.

    abstract:BACKGROUND:Thymidylate synthase (TS) and Topoisomerase I (Topo I) are significant biomarkers in colorectal cancer (CRC). We aimed to study the expression of TS and Topo I in patients with resected CRC who received adjuvant chemotherapy and correlated it with clinical outcome. METHODS:All patients diagnosed with CRC be...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-339

    authors: Kostopoulos I,Karavasilis V,Karina M,Bobos M,Xiros N,Pentheroudakis G,Kafiri G,Papakostas P,Vrettou E,Fountzilas G

    更新日期:2009-09-24 00:00:00

  • Favorable prognostic value of SOCS2 and IGF-I in breast cancer.

    abstract:BACKGROUND:Suppressor of cytokine signaling (SOCS) proteins comprise a protein family, which has initially been described as STAT induced inhibitors of the Jak/Stat pathway. Recent in vivo and in vitro studies suggest that SOCS proteins are also implicated in cancer. The STAT5 induced IGF-I acts as an endocrine and par...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/1471-2407-7-136

    authors: Haffner MC,Petridou B,Peyrat JP,Révillion F,Müller-Holzner E,Daxenbichler G,Marth C,Doppler W

    更新日期:2007-07-25 00:00:00

  • Prognostic role of myeloid-derived suppressor cells in cancers: a systematic review and meta-analysis.

    abstract:BACKGROUND:Myeloid-derived suppressor cells (MDSCs) is a heterogeneous population of immature myeloid cells, inhibiting both the innate and adaptive immunity. Recent studies validated that MDSCs caused immune suppression and promoted cancer progression through various mechanisms. However, the prognostic value of MDSCs ...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-018-5086-y

    authors: Ai L,Mu S,Wang Y,Wang H,Cai L,Li W,Hu Y

    更新日期:2018-12-05 00:00:00

  • Use of NQO1 status as a selective biomarker for oesophageal squamous cell carcinomas with greater sensitivity to 17-AAG.

    abstract:BACKGROUND:Oesophageal squamous cell carcinoma (OSCC) is a major health burden in Sub-Saharan Africa, and novel chemotherapies are urgently required to combat this disease. The heat shock protein 90 (HSP90) inhibitor 17-N-allylamino-17-demethoxygeldanamycin (17-AAG) has previously been proposed as a possible candidate ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-334

    authors: Hadley KE,Hendricks DT

    更新日期:2014-05-15 00:00:00

  • Development of a risk-stratification scoring system for predicting lymphovascular invasion in breast cancer.

    abstract:BACKGROUND:Lymphovascular invasion (LVI) is a vital risk factor for prognosis across cancers. We aimed to develop a scoring system for stratifying LVI risk in patients with breast cancer. METHODS:A total of 301 consecutive patients (mean age, 49.8 ± 11.0 years; range, 29-86 years) with breast cancer confirmed by patho...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-6578-0

    authors: Ni-Jia-Ti MY,Ai-Hai-Ti DL,Huo-Jia AS,Wu-Mai-Er PL,A-Bu-Li-Zi AB,Shi Y,Rou-Zi NE,Su WJ,Dai GZ,Da-Mo-la MH

    更新日期:2020-02-03 00:00:00

  • Resilience and associated factors among Chinese patients diagnosed with oral cancer.

    abstract:BACKGROUND:Resilience has been linked to psychological adaptation to many challenging life events. The present study aims to explore the level of resilience in oral cancer patients and the key factors associated with resilience, and to evaluate the relationship between resilience and anxiety. METHODS:A multiple center...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/s12885-019-5679-0

    authors: Gao Y,Yuan L,Pan B,Wang L

    更新日期:2019-05-14 00:00:00

  • Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging.

    abstract:BACKGROUND:Merkel cell carcinoma (MCC) is a rare cutaneous neoplasm with increasing incidence, aggressive behavior and poor prognosis. Somatostatin receptors (SSTR) are expressed in MCC and represent a potential target for both imaging and treatment. METHODS:To non-invasively assess SSTR expression in MCC using PET an...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-268

    authors: Buder K,Lapa C,Kreissl MC,Schirbel A,Herrmann K,Schnack A,Bröcker EB,Goebeler M,Buck AK,Becker JC

    更新日期:2014-04-17 00:00:00

  • Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age.

    abstract:BACKGROUND:To evaluate the safety and efficacy of intra-arterial chemotherapy (IAC) for the primary or secondary treatment of infants diagnosed with advanced retinoblastoma before 3 months of age. METHODS:This single-center retrospective study included 39 infants (42 eyes) aged ≤3 months who were diagnosed with unilat...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5844-5

    authors: Chen Q,Zhang B,Dong Y,Mo X,Zhang L,Xia J,Zhang J,Zhang S

    更新日期:2019-07-15 00:00:00

  • KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcome.

    abstract:BACKGROUND:Tumor genotype plays a crucial role in clinical management of GIST. Whether genetic polymorphism of KIT may influence GIST patient outcome is unclear. METHODS:We investigated the biological and clinical significance of the presence of KIT exon 10 variant (c.1621 A > C), KIT (L541), in a transfected cell lin...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1817-5

    authors: Brahmi M,Alberti L,Dufresne A,Ray-Coquard I,Cassier P,Meeus P,Decouvelaere AV,Ranchère-Vince D,Blay JY

    更新日期:2015-10-24 00:00:00

  • Characterization of three new serous epithelial ovarian cancer cell lines.

    abstract:BACKGROUND:Cell lines constitute a powerful model to study cancer, and here we describe three new epithelial ovarian cancer (EOC) cell lines derived from poorly differentiated serous solid tumors (TOV-1946, and TOV-2223G), as well as the matched ascites for one case (OV-1946). METHODS:In addition to growth parameters,...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-152

    authors: Ouellet V,Zietarska M,Portelance L,Lafontaine J,Madore J,Puiffe ML,Arcand SL,Shen Z,Hébert J,Tonin PN,Provencher DM,Mes-Masson AM

    更新日期:2008-05-28 00:00:00

  • Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma.

    abstract:BACKGROUND:Hepatocellular carcinoma (HCC) is one of the most common cancers in the world. SFRP1 (the secreted frizzled-related protein 1), a putative tumor suppressor gene mapped onto chromosome 8p12-p11.1, the frequent loss of heterozygosity (LOH) region in human HCC, encodes a Wingless-type (Wnt) signaling antagonist...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-7-126

    authors: Huang J,Zhang YL,Teng XM,Lin Y,Zheng DL,Yang PY,Han ZG

    更新日期:2007-07-12 00:00:00

  • MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.

    abstract:BACKGROUND:Choriocarcinoma is a gestational trophoblastic tumor which causes high mortality if left untreated. MicroRNAs (miRNAs) are small non protein-coding RNAs which inhibit target gene expression. The role of miRNAs in choriocarcinoma, however, is not well understood. In this study, we examined the effect of miR-3...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-25

    authors: Pang RT,Leung CO,Lee CL,Lam KK,Ye TM,Chiu PC,Yeung WS

    更新日期:2013-01-18 00:00:00

  • Pursuing equity in cancer care: implementation, challenges and preliminary findings of a public cancer referral center in rural Rwanda.

    abstract:BACKGROUND:Cancer services are inaccessible in many low-income countries, and few published examples describe oncology programs within the public sector. In 2011, the Rwanda Ministry of Health (RMOH) established Butaro Cancer Center of Excellence (BCCOE) to expand cancer services nationally. In hopes of informing cance...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2256-7

    authors: Tapela NM,Mpunga T,Hedt-Gauthier B,Moore M,Mpanumusingo E,Xu MJ,Nzayisenga I,Hategekimana V,Umuhizi DG,Pace LE,Bigirimana JB,Wang J,Driscoll C,Uwizeye FR,Drobac PC,Ngoga G,Shyirambere C,Muhayimana C,Lehmann L,Shulma

    更新日期:2016-03-18 00:00:00

  • Cervix carcinoma is associated with an up-regulation and nuclear localization of the dual-specificity protein phosphatase VHR.

    abstract:BACKGROUND:The 21-kDa Vaccinia virus VH1-related (VHR) dual-specific protein phosphatase (encoded by the DUSP3 gene) plays a critical role in cell cycle progression and is itself regulated during the cell cycle. We have previously demonstrated using RNA interference that cells lacking VHR arrest in the G1 and G2 phases...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-147

    authors: Henkens R,Delvenne P,Arafa M,Moutschen M,Zeddou M,Tautz L,Boniver J,Mustelin T,Rahmouni S

    更新日期:2008-05-27 00:00:00

  • Diagnostic intervals before and after implementation of cancer patient pathways - a GP survey and registry based comparison of three cohorts of cancer patients.

    abstract:BACKGROUND:From 2008, Danish general practitioners could refer patients suspected of having cancer to standardised cancer patient pathways (CPPs). We aimed to compare the length of the diagnostic interval in 2010 with the length of the diagnostic interval before (2004/05) and during (2007/08) the implementation of CPPs...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1317-7

    authors: Jensen H,Tørring ML,Olesen F,Overgaard J,Fenger-Grøn M,Vedsted P

    更新日期:2015-04-23 00:00:00

  • Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.

    abstract:BACKGROUND:The development of metastases is a negative prognostic parameter for the clinical outcome of breast cancer. Bone constitutes the first site of distant metastases for many affected women. The purpose of this retrospective multicentre study was to evaluate if and how different variables such as primary tumour ...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/s12885-016-2345-7

    authors: Diessner J,Wischnewsky M,Stüber T,Stein R,Krockenberger M,Häusler S,Janni W,Kreienberg R,Blettner M,Schwentner L,Wöckel A,Bartmann C

    更新日期:2016-05-12 00:00:00

  • Decreased expression of the β2 integrin on tumor cells is associated with a reduction in liver metastasis of colorectal cancer in mice.

    abstract:BACKGROUND:Lymphocyte Function-Associated Antigen-1 (LFA-1; CD18/CD11a) is one of the main adhesion molecules used by immune cells to infiltrate the liver under inflammatory conditions. Recently, the expression of this integrin has also been reported on several solid tumors, including colorectal cancer. However, its fu...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3823-2

    authors: Benedicto A,Marquez J,Herrero A,Olaso E,Kolaczkowska E,Arteta B

    更新日期:2017-12-06 00:00:00

  • Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.

    abstract:BACKGROUND:Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer related death in the world with a five-year survival rate of less than 5%. Not all PDAC are the same, because there exist intra-tumoral heterogeneity between PDAC, which poses a great challenge to personalized treatments for PDAC. ...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-018-4546-8

    authors: Zhao L,Zhao H,Yan H

    更新日期:2018-05-29 00:00:00

  • A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time.

    abstract:BACKGROUND:Cancer vaccine is one of the attractive treatment modalities for patients with castration-resistant prostate cancer (CRPC). However, because of delayed immune responses, its clinical benefits, besides for overall survival (OS), are not well captured by the World Health Organization (WHO) and Response Evaluat...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-613

    authors: Noguchi M,Moriya F,Suekane S,Ohnishi R,Matsueda S,Sasada T,Yamada A,Itoh K

    更新日期:2013-12-30 00:00:00

  • Target enzyme mutations are the molecular basis for resistance towards pharmacological inhibition of nicotinamide phosphoribosyltransferase.

    abstract:BACKGROUND:Inhibitors of nicotinamide phosphoribosyltransferase (NAMPT) are promising cancer drugs currently in clinical trials in oncology, including APO866, CHS-828 and the CHS-828 prodrug EB1627/GMX1777, but cancer cell resistance to these drugs has not been studied in detail. METHODS:Here, we introduce an analogue...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-677

    authors: Olesen UH,Petersen JG,Garten A,Kiess W,Yoshino J,Imai S,Christensen MK,Fristrup P,Thougaard AV,Björkling F,Jensen PB,Nielsen SJ,Sehested M

    更新日期:2010-12-12 00:00:00

  • Prognostic models for breast cancer: a systematic review.

    abstract:BACKGROUND:Breast cancer is the most common cancer in women worldwide, with a great diversity in outcomes among individual patients. The ability to accurately predict a breast cancer outcome is important to patients, physicians, researchers, and policy makers. Many models have been developed and tested in different set...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5442-6

    authors: Phung MT,Tin Tin S,Elwood JM

    更新日期:2019-03-14 00:00:00

  • Correlation analyses between pre- and post-operative adverse events in gastric cancer patients receiving preoperative treatment and gastrectomy.

    abstract:BACKGROUNDS:Preoperative chemotherapy (PCT) and chemoradiotherapy (PCRT) showed promising results for gastric cancers. However, the influence of preoperative adverse events (AEs) on postoperative complications remains unknown. The aim of this study was to identify correlations between them. METHODS:Clinical data and l...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2066-y

    authors: Li SX,Seo SH,Choi YY,Nakagawa M,An JY,Kim HI,Cheong JH,Hyung WJ,Noh SH

    更新日期:2016-01-19 00:00:00

  • Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer.

    abstract:BACKGROUND:Chemoresistance is one of the main problems in treatment of cancer. Periostin (PN) is a stromal protein which is mostly secreted from cancer associated fibroblasts in the tumor microenvironment and can promote cancer progression including cell survival, metastasis, and chemoresistance. The main objective of ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07761-w

    authors: Oo KK,Kamolhan T,Soni A,Thongchot S,Mitrpant C,O-Charoenrat P,Thuwajit C,Thuwajit P

    更新日期:2021-01-14 00:00:00